Methylphenidate reduces functional connectivity of nucleus accumbens in brain reward circuit

Psychopharmacology

Volumn 229, Issue 2, 2013, Pages 219-226

  Ramaekers, J G ^a   Evers, E A ^a   Theunissen, E L ^a   Kuypers, K P C ^a   Goulas, A ^a   Stiers, P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Dopaminergic; Drug abuse; Limbic circuit

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ADULT; ARTICLE; BASAL GANGLION; BRAIN REGION; BRAIN REWARD CIRCUIT; CONNECTOME; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPAMINE RELEASE; DOUBLE BLIND PROCEDURE; DRUG METABOLISM; FEMALE; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEMISPHERE; HUMAN; HUMAN EXPERIMENT; LIMBIC CORTICAL CIRCUIT; MALE; MEDIAL DORSAL NUCLEUS; MEMBRANE STEADY POTENTIAL; NORMAL HUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; REGION OF INTEREST; SINGLE DRUG DOSE; SUBCORTICAL CIRCUIT; SUBTHALAMIC NUCLEUS; TEMPORAL CORTEX; THALAMUS; VENTRAL PALLIDUM;

ADULT; BRAIN MAPPING; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, LIQUID; DOUBLE-BLIND METHOD; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MASS SPECTROMETRY; METHYLPHENIDATE; NUCLEUS ACCUMBENS; OXYGEN; REWARD; YOUNG ADULT;

EID: 84883464387     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3105-x     Document Type: Article

References (40)

1. Achard S, Bullmore E (2007) Efficiency and cost of economical brain functional networks. PLoS Comput Biol 3:e17
2. Alexander GE, DeLong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357-381
3. Bechara A (2005) Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat Neurosci 8:1458-1463
4. Bonelli RM, Cummings JL (2007) Frontal-subcortical circuitry and behavior. Dialogues Clin Neurosci 9:141-151
5. Carboni E, Silvagni A, Valentini V, Di Chiara G (2003) Effect of amphetamine, cocaine and depolarization by high potassium on extracellular dopamine in the nucleus accumbens shell of SHR rats. An in vivo microdyalisis study. Neurosci Biobehav Rev 27:653-659
6. Cauda F, Cavanna AE, D'Agata F, Sacco K, Duca S, Geminiani GC (2011) Functional connectivity and coactivation of the nucleus accumbens: a combined functional connectivity and structure-based meta-analysis. J Cogn Neurosci 23:2864-2877
7. Chao-Gan Y, Yu-Feng Z (2010) DPARSF: a MATLAB toolbox for "pipeline" data analysis of resting-state fMRI. Front Syst Neurosci 4:13
8. Chong SL, Claussen CM, Dafny N (2012) Nucleus accumbens neuronal activity in freely behaving rats is modulated following acute and chronic methylphenidate administration. Brain Res Bull 87:445-456
9. Cole DM, Oei NY, Soeter RP, Both S, van Gerven JM, Rombouts SA, Beckmann CF (2012) Dopamine-dependent architecture of cortico-subcortical network connectivity. Cerebr Cortex. doi: 10.1093/cercor/bhs136
10. Cummings JL (1993) Frontal-subcortical circuits and human behavior. Arch Neurol 50:873-880
11. Dagher A, Robbins TW (2009) Personality, addiction, dopamine: insights from Parkinson's disease. Neuron 61:502-510
12. Di Martino A, Scheres A, Margulies DS, Kelly AM, Uddin LQ, Shehzad Z, Biswal B, Walters JR, Castellanos FX, Milham MP (2008) Functional connectivity of human striatum: a resting state FMRI study. Cerebr Cortex 18:2735-2747
13. Faure A, Richard JM, Berridge KC (2010) Desire and dread from the nucleus accumbens: cortical glutamate and subcortical GABA differentially generate motivation and hedonic impact in the rat. PLoS One 5:e11223
14. Goldstein RZ, Volkow ND (2011a) Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci 12:652-669
15. Goldstein RZ, Volkow ND (2011b) Oral methylphenidate normalizes cingulate activity and decreases impulsivity in cocaine addiction during an emotionally salient cognitive task. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 36:366-367
16. Gu H, Salmeron BJ, Ross TJ, Geng X, Zhan W, Stein EA, Yang Y (2010) Mesocorticolimbic circuits are impaired in chronic cocaine users as demonstrated by resting-state functional connectivity. NeuroImage 53:593-601
17. Honey GD, Suckling J, Zelaya F, Long C, Routledge C, Jackson S, Ng V, Fletcher PC, Williams SC, Brown J, Bullmore ET (2003) Dopaminergic drug effects on physiological connectivity in a human cortico-striato-thalamic system. Brain J Neurol 126:1767-1781
18. Hong LE, Gu H, Yang Y, Ross TJ, Salmeron BJ, Buchholz B, Thaker GK, Stein EA (2009) Association of nicotine addiction and nicotine's actions with separate cingulate cortex functional circuits. Arch Gen Psychiatry 66:431-441
19. Kalivas PW, Volkow N, Seamans J (2005) Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron 45:647-650
20. Kalivas PW, Volkow ND (2005) The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162:1403-1413
21. Kalivas PW, Volkow ND (2011) New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol Psychiatry 16:974-986
22. Kelly C, de Zubicaray G, Di Martino A, Copland DA, Reiss PT, Klein DF, Castellanos FX, Milham MP, McMahon K (2009) l-Dopa modulates functional connectivity in striatal cognitive and motor networks: a double-blind placebo-controlled study. J Neurosci Off J Soc Neurosci 29:7364-7378
23. Kollins SH, English J, Robinson R, Hallyburton M, Chrisman AK (2009) Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD). Psychopharmacology 204:73-83
24. Lee L, Kepple J, Wang Y, Freestone S, Bakhtiar R, Hossain M (2003) Bioavailability of modified-release methylphenidate: influence of high-fat breakfast when administered intact and when capsule content sprinkled on applesauce. Biopharm Drug Dispos 24:233-243
25. McMahon K, Copland DA, De Zubicaray G, MB (2006) Effects of levodopa administration on cerebral functional connectivity 12th Annual Meeting of the Organization for Human Brain Mapping. Florence, Italy
26. Murphy K, Birn RM, Handwerker DA, Jones TB, Bandettini PA (2009) The impact of global signal regression on resting state correlations: are anti-correlated networks introduced? NeuroImage 44:893-905
27. Nestler EJ (2005) Is there a common molecular pathway for addiction? Nat Neurosci 8:1445-1449
28. Parasrampuria DA, Schoedel KA, Schuller R, Silber SA, Ciccone PE, Gu J, Sellers EM (2007) Do formulation differences alter abuse liability of methylphenidate? A placebo-controlled, randomized, double-blind, crossover study in recreational drug users. J Clin Psychopharmacol 27:459-467
29. Perreault ML, Hasbi A, O'Dowd BF, George SR (2011) The dopamine d1-d2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in Basal Ganglia. Front Neuroanat 5:31
30. Pierce RC, Kumaresan V (2006) The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev 30:215-238
31. Podet A, Lee MJ, Swann AC, Dafny N (2010) Nucleus accumbens lesions modulate the effects of methylphenidate. Brain Res Bull 82:293-301
32. Spencer TJ, Biederman J, Ciccone PE, Madras BK, Dougherty DD, Bonab AA, Livni E, Parasrampuria DA, Fischman AJ (2006) PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate. Am J Psychiatry 163:387-395
33. Tomasi D, Volkow ND, Wang R, Carrillo JH, Maloney T, Alia-Klein N, Woicik PA, Telang F, Goldstein RZ (2010) Disrupted functional connectivity with dopaminergic midbrain in cocaine abusers. PLoS One 5:e10815
34. Volkow ND, Fowler JS, Wang G, Ding Y, Gatley SJ (2002) Mechanism of action of methylphenidate: insights from PET imaging studies. J Atten Disord 6(Suppl 1):S31-S43
35. Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F (2007) Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol 64:1575-1579
36. Volkow ND, Wang GJ, Fowler JS, Ding YS (2005a) Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1410-1415
37. Volkow ND, Wang GJ, Fowler JS, Hitzemann R, Gatley SJ, Dewey SS, Pappas N (1998) Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: a PET study. Am J Psychiatry 155:200-206
38. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Gifford A, Hitzemann R, Ding YS, Pappas N (1999) Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am J Psychiatry 156:1440-1443
39. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F (2011) Addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci USA 108:15037-15042
40. Volkow ND, Wang GJ, Ma Y, Fowler JS, Wong C, Ding YS, Hitzemann R, Swanson JM, Kalivas P (2005b) Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction. J Neurosci Off J Soc Neurosci 25:3932-3939